Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Exchange Rate Effect (2023 - 2025)

Lisata Therapeutics' Exchange Rate Effect history spans 6 years, with the latest figure at $2000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 103.08% year-over-year to $2000.0; the TTM value through Dec 2025 reached $11000.0, up 120.0%, while the annual FY2025 figure was $11000.0, 120.0% up from the prior year.
  • Exchange Rate Effect reached $2000.0 in Q4 2025 per LSTA's latest filing, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $75000.0 in Q3 2023 to a low of -$76000.0 in Q4 2023.
  • Average Exchange Rate Effect over 3 years is -$5000.0, with a median of $2000.0 recorded in 2025.
  • The largest YoY upside for Exchange Rate Effect was 425.0% in 2024 against a maximum downside of 685.71% in 2024.
  • A 3-year view of Exchange Rate Effect shows it stood at -$76000.0 in 2023, then increased by 14.47% to -$65000.0 in 2024, then soared by 103.08% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Exchange Rate Effect are $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $5000.0 (Q2 2025).